A detailed history of Silvercrest Asset Management Group LLC transactions in Neuronetics, Inc. stock. As of the latest transaction made, Silvercrest Asset Management Group LLC holds 1,193,709 shares of STIM stock, worth $1.28 Million. This represents 0.02% of its overall portfolio holdings.

Number of Shares
1,193,709
Previous 2,387,418 50.0%
Holding current value
$1.28 Million
Previous $4.3 Million 50.01%
% of portfolio
0.02%
Previous 0.02%

Shares

18 transactions
Quarter Operation Price Per share shares change shares Held SEC Form
Q2 2024

Aug 14, 2024

SELL
$1.73 - $4.81 $2.07 Million - $5.74 Million
-1,193,709 Reduced 50.0%
1,193,709 $2.15 Million
Q2 2024

Aug 14, 2024

BUY
$1.73 - $4.81 $2.09 Million - $5.82 Million
1,209,053 Added 102.6%
2,387,418 $4.3 Million
Q1 2024

May 15, 2024

BUY
$2.68 - $4.8 $139,041 - $249,028
51,881 Added 4.61%
1,178,365 $5.61 Million
Q3 2023

Nov 14, 2023

SELL
$1.29 - $2.22 $3,800 - $6,540
-2,946 Reduced 0.26%
1,126,484 $1.52 Million
Q2 2023

Aug 14, 2023

BUY
$2.07 - $2.92 $330,038 - $465,561
159,439 Added 16.44%
1,129,430 $2.43 Million
Q1 2023

May 15, 2023

BUY
$2.81 - $6.71 $507,424 - $1.21 Million
180,578 Added 22.87%
969,991 $2.82 Million
Q4 2022

Feb 14, 2023

SELL
$2.74 - $6.87 $19,056 - $47,780
-6,955 Reduced 0.87%
789,413 $5.42 Million
Q3 2022

Nov 14, 2022

SELL
$2.35 - $4.66 $50,929 - $100,991
-21,672 Reduced 2.65%
796,368 $2.53 Million
Q2 2022

Aug 15, 2022

SELL
$2.09 - $3.71 $76,094 - $135,077
-36,409 Reduced 4.26%
818,040 $2.63 Million
Q1 2022

May 16, 2022

BUY
$2.84 - $4.52 $22,365 - $35,595
7,875 Added 0.93%
854,449 $2.59 Million
Q4 2021

Feb 14, 2022

BUY
$3.87 - $6.59 $1.16 Million - $1.98 Million
300,651 Added 55.07%
846,574 $3.78 Million
Q3 2021

Nov 15, 2021

SELL
$6.22 - $15.54 $77,650 - $194,001
-12,484 Reduced 2.24%
545,923 $3.58 Million
Q2 2021

Aug 16, 2021

BUY
$10.15 - $17.25 $946,111 - $1.61 Million
93,213 Added 20.04%
558,407 $8.95 Million
Q1 2021

May 17, 2021

BUY
$10.6 - $21.27 $2.42 Million - $4.85 Million
227,914 Added 96.05%
465,194 $5.75 Million
Q4 2020

Feb 16, 2021

BUY
$4.95 - $11.45 $1.17 Million - $2.72 Million
237,280 New
237,280 $2.64 Million
Q1 2020

May 15, 2020

SELL
$1.28 - $4.5 $365,518 - $1.29 Million
-285,561 Closed
0 $0
Q4 2019

Feb 14, 2020

SELL
$4.03 - $9.22 $196,768 - $450,175
-48,826 Reduced 14.6%
285,561 $1.28 Million
Q3 2019

Nov 14, 2019

BUY
$8.31 - $13.03 $2.78 Million - $4.36 Million
334,387 New
334,387 $2.78 Million

Others Institutions Holding STIM

About Neuronetics, Inc.


  • Ticker STIM
  • Exchange NASDAQ
  • Sector Healthcare
  • Industry Diagnostics & Research
  • Shares Outstandng 27,022,800
  • Market Cap $28.9M
  • Description
  • Neuronetics, Inc., a commercial stage medical technology company, designs, develops, and markets products for patients with neurohealth disorders in the United States and internationally. The company offers NeuroStar Advanced Therapy System, a non-invasive and non-systemic office-based treatment to treat adult patients with major depressive diso...
More about STIM
Track This Portfolio

Track Silvercrest Asset Management Group LLC Portfolio

Follow Silvercrest Asset Management Group LLC and customize your updates to receive the information that matters most to you.

Portfolio Update

Get notified when there are updates to the investment portfolio of Silvercrest Asset Management Group LLC, based on Form 13F filings with the SEC.

News

Stay updated on Silvercrest Asset Management Group LLC with notifications on news.